Dec 16, 2025 03:13AM Jefferies Downgrades Generation Bio (GBIO) to Hold

Dec 12, 2025 08:44AM Benchmark Reiterates Buy Rating on XOMA, Ltd. (XOMA) Despite Rezolute Setback

Dec 11, 2025 10:49AM XOMA, Ltd. (XOMA) PT Lowered to $97 at H.C. Wainwright

Dec 11, 2025 10:20AM XOMA, Ltd. (XOMA) PT Lowered to $45 at Leerink Partners

Dec 9, 2025 06:38AM Lucid Capital Markets Starts XOMA, Ltd. (XOMA) at Buy

Dec 5, 2025 07:45AM XOMA Royalty completes acquisition of Mural Oncology

Dec 3, 2025 04:32PM Irish court approves XOMA Royalty's acquisition of Mural Oncology

Nov 26, 2025 09:00AM Mural Oncology sets final cash payout at $2.035 per share for XOMA deal

Nov 13, 2025 04:46AM XOMA, Ltd. (XOMA) PT Raised to $58 at Leerink Partners

Nov 12, 2025 08:06AM XOMA (XOMA) Tops Q3 EPS by 79c

Oct 24, 2025 04:26PM Mural Oncology shareholders approve XOMA Royalty acquisition

Oct 17, 2025 11:47AM XOMA and LAVA amend purchase agreement with lower cash offer

Oct 1, 2025 01:20PM Canaccord #1 Key Risk to AxoGen, Inc. (AXGN): 'the FDA running out of carryover funding and needing to halt work'

Oct 1, 2025 01:13PM FDA on Operations During Shutdown: 'FDA will not be able to accept any regulatory submissions for FY 2026 that require a fee payment'

Sep 24, 2025 06:00AM ESSA Pharma amends deal terms, cuts shareholder payout to $0.12 per share

Sep 9, 2025 08:41AM XOMA, Ltd. (XOMA) PT Raised to $50 at Benchmark

Aug 21, 2025 06:35AM H.C. Wainwright Reiterates Buy Rating on XOMA, Ltd. (XOMA)

Aug 20, 2025 08:30AM XOMA to acquire Mural Oncology for up to $2.24 per share in cash

Aug 14, 2025 06:21AM Leerink Partners Reiterates Outperform Rating on XOMA, Ltd. (XOMA)

Aug 13, 2025 08:28AM XOMA (XOMA) Tops Q2 EPS by 64c

Aug 4, 2025 07:00AM XOMA Royalty to acquire HilleVax for $1.95 per share plus contingent rights

Jul 14, 2025 08:02AM ESSA Pharma to be acquired by XenoTherapeutics in all-cash deal

Jun 27, 2025 07:30AM Turnstone Biologics (TSBX) to be Acquired by XOMA Royalty (XOMA) for $0.34 in Cash Per Share Plus a Contingent Value Right

May 28, 2025 06:55AM H.C. Wainwright Reiterates Buy Rating on XOMA, Ltd. (XOMA)

May 13, 2025 07:53AM XOMA (XOMA) Tops Q1 EPS by 35c

Apr 14, 2025 07:30AM XOMA (XOMA) Completes Sale of Kinnate Pipeline Assets

Mar 28, 2025 06:43AM H.C. Wainwright Reiterates Buy Rating on XOMA, Ltd. (XOMA)

Mar 19, 2025 06:47AM H.C. Wainwright Reiterates Buy Rating on XOMA, Ltd. (XOMA)

Feb 25, 2025 07:27AM Ligand Pharma (LGND) Leads $75 Million Royalty Financing in Castle Creek Biosciences

Feb 3, 2025 06:36AM XOMA, Ltd. (XOMA) PT Lowered to $104 at H.C. Wainwright

Jan 8, 2025 09:28AM H.C. Wainwright Reiterates Buy Rating on XOMA, Ltd. (XOMA)

Dec 3, 2024 06:48AM XOMA, Ltd. (XOMA) PT Raised to $123 at H.C. Wainwright

Dec 2, 2024 07:31AM XOMA (XOMA) Acquires Pulmokine for $20 Million Adding the Royalty and Milestone Interest in Seralutinib, a Phase 3 Asset, to Its Portfolio

Oct 22, 2024 08:02AM Twist Bioscience Corporation (TWST) Enters into Royalty Purchase Agreement with XOMA Royalty (XOMA) for $15 Million in Cash

Oct 22, 2024 08:00AM XOMA (XOMA) Significantly Expands its Royalty and Milestone Portfolio

Sep 23, 2024 06:38AM H.C. Wainwright Reiterates Buy Rating on XOMA, Ltd. (XOMA)

Sep 23, 2024 06:31AM XOMA (XOMA) Announces FDA Approval of MIPLYFFA for Patients with Niemann-Pick Disease Type C

Aug 14, 2024 06:43AM XOMA, Ltd. (XOMA) PT Raised to $117 at H.C. Wainwright

Aug 13, 2024 07:37AM XOMA (XOMA) Tops Q2 EPS by $1.10

Jun 12, 2024 07:30AM XOMA (XOMA) Receives $8.1M Milestone Related to Day One Biopharmaceuticals’ Sale of its Priority Review Voucher